Verastem, Inc.·4

Mar 24, 4:39 PM ET

Calkins Daniel 4

4 · Verastem, Inc. · Filed Mar 24, 2025

Insider Transaction Report

Form 4
Period: 2025-03-20
Calkins Daniel
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-03-24$7.04/sh26$18386,348 total
  • Sale

    Common Stock

    2025-03-20$6.89/sh65$44886,374 total
Footnotes (1)
  • [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file
  • 4
    tm2510143-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT